Successful implementation and use of patient-facing digital technologies (PT) in clinical trials requires collaborative effort and input from key stakeholders including sponsors, clinical research sites, patients and technology vendors. Despite this, there is often an unequal distribution of voices during the process of PT implementation, with patients, clinical research sites, and vendors failing to always be heard.
Understanding this, the TransCelerate Patient Technology initiative set out to engage all three stakeholders to better understand successful ways of working during the implementation of PT in clinical trials. The result is the Patient Technology Toolkit, which contains guidance, considerations and best practices for utilization by sponsors, clinical research sites and vendors.
Patient technology is any technology with which patients interact to participate in clinical trial activities. This can include, but isn’t limited to, technologies that collect clinical data (e.g. an ePRO or wearable device), non-clinical data (e.g. patient engagement application), or technologies that do not collect data but facilitate patient participation in a study (e.g. a telehealth platform).
Attendees will learn about the proposed approaches for utilizing patient, vendor and site input into the design & implementation of clinical trials with patient technology.
- Sponsor Companies
- Individuals involved in clinical trial activities (strategy development, execution, regulatory)
- Individuals working in innovation teams
- Patient Technology Vendors
- Clinical Research Sites
- Anyone interested in better understanding effective utilization of patient, vendor and site voice during design of clinical trials